ArticleClinical and experimental medicine2025
Decreased STING predicts adverse efficacy in bortezomib regimens and poor survival in multiple myeloma.
Yang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it